A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence.
This article was originally published on MedicalXpress.com
Two-dose recombinant shingles vaccine found to be effective even accounting for prior receipt of live shingles vaccine
You may also be interested in:
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
PetVet Dx Revolutionizes Wildlife Conservation with AI and Molecular Diagnostics to Combat Incurable CWD in Deer and Elk
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
Read More:
-
The idea that building better health care systems can improve and save people’s lives may seem obvious, but until now there has been little published [...]
-
A study published in Environment International concludes that air pollution during pregnancy is associated with slower brain maturation in newborns. It is the first study [...]
-
The faster a child takes bites during a meal or snack, the greater risk they have for developing obesity, according to researchers in the Penn [...]
